TAZIP

4G/0,5G INF PLV SOL 10

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 27.01.2021
Interruption of marketing 01.07.2020 0113424, 0141263
Manufacturing reasons 2.1.2021
Interruption of marketing 09.04.2020 0113424, 0141263
Manufacturing reasons 30.06.2020
Resumption of marketing 06.01.2020
Interruption of marketing 29.04.2019 0141263
Manufacturing reasons leden 2020
Interruption of marketing 29.04.2019 0141263
Manufacturing reasons 10.09.2019
Interruption of marketing 29.04.2019 0141263
Manufacturing reasons 29.06.2019
Resumption of marketing 04.02.2019
Interruption of marketing 31.10.2018 lék je nenahraditelný Manufacturing reasons 20.02.2019
Resumption of marketing 20.09.2018
Interruption of marketing 12.04.2018 Lék není nahraditelný
Placing on the market 11.03.2010
Placing on the market 22.03.2010

All reports are available in the Overview.

Back to list